Experience

Our commercially savvy lawyers regularly lead strategic transactions and complex disputes for clients in a variety of industries and regions. We’ve included a small selection of matters for your convenience.
Practice
Industry
Region
Featured Matters

Metric Capital Partners in the formation of MCP Private Capital Fund IV, a €1.2 billion European special opportunities fund.

Debevoise & Plimpton LLP has advised Metric Capital Partners (“Metric”) in its successful fundraising for MCP Private Capital Fund IV (“MCP IV”), its European special opportunities fund. Read More>

An infrastructure fund managed by EQT in a subscription facility of initially €2.7 billion (with an upper limit of around €5 billion) with a large club of lenders. The facility incorporates innovative environmental, social and governance mechanics, which impact the margin payable to the lenders.

Debevoise & Plimpton LLP has advised a private equity fund managed by EQT in a new €2.7 billion subscription credit facility (with an upper limit of around €5 billion), which incorporates innovative environmental, social and governance (“ESG”) mechanics. Read More>

StepStone Group as lead investor in the $670 million closing of Ampersand Continuation Fund, together with related investment vehicles, formed to acquire the equity interests of three portfolio companies previously held by multiple mature Ampersand funds.

Debevoise & Plimpton LLP has advised StepStone Group, a global private markets investment firm, as lead investor in the Ampersand-sponsored continuation vehicle, Ampersand Continuation Fund ("AMP-CF"), which is oversubscribed and closing at $670 million. AMP-CF was formed to acquire the equity interests of three portfolio companies, Ampersand 2006 Limited Partnership, Ampersand 2011 Limited Partnership and Ampersand 2014 Limited Partnership, previously held by multiple mature Ampersand funds. For more information, please see the company’s press release here. Read More>

Precision Medical Group in its investment from funds managed by Blackstone.

Debevoise & Plimpton LLP has advised Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, and its founders and shareholders in a major investment and recapitalization led by funds managed by Blackstone. Read More>

Schneider Electric in its acquisition of an 80% controlling stake in Operation Technology / ETAP Automation, the leading software platform for electrical power systems modeling and simulation.

Debevoise & Plimpton LLP is advising Schneider Electric in its acquisition of an 80% controlling stake in Operation Technology Inc./ETAP Automation Inc., the leading software platform for electrical power systems modeling and simulation, including an agreement to acquire the remaining 20% in 2025. For more information, please see the company’s press release. Read More>